Physician profile
Ellie E Samadani
NPI 1033268503
$2,524.00
in general payments reported to CMS, 2019-2025
18 companies · $717 in 2025
The $717 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.59 · 2022: $312 · 2023: $615 · 2024: $803 · 2025: $717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,135.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $347.05 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Harrow Eye, LLC | $267.68 | 2024-2025 | Vevye |
| Dompe US, INC. | $251.19 | 2024-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $249.14 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $239.63 | 2023-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Abbvie INC. | $216.37 | 2022-2024 | Alphagan P, Lumigan, Vuity |
| Horizon Therapeutics Plc | $173.28 | 2022-2023 | Tepezza |
| Alcon Vision LLC | $146.17 | 2023-2025 | Tryptyr, Wavelight Refractive Suite, Eysuvis |
| Glaukos Corporation | $125.53 | 2022 | |
| Sun Pharmaceutical Industries INC. | $105.10 | 2024-2025 | |
| Sight Sciences, INC. | $94.28 | 2022 | |
| Mallinckrodt Hospital Products INC. | $65.59 | 2023-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $57.81 | 2021-2023 | |
| Thea Pharma INC. | $57.21 | 2025 | Iyuzeh |
| Allergan, INC. | $56.09 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $32.08 | 2024 | Tepezza |
| Ani Pharmaceuticals, INC. | $22.09 | 2024 | Purified Cortrophin Gel |
| Rxsight INC | $17.71 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellie Samadani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.